Abstract:Abstract Purpose: Liver metastasis is one of the major causes of death in colorectal cancer (CRC) patients. But the process is still unknown. Here, we analyzed genetic differences between primary tumors associated with liver metastasis and those without liver metastasis and predicted clinical significance. Experimental design: Eight primary tumors associated with liver metastasis and twelve without liver metastasis of CRC were analyzed by whole-exome sequencing. The functional characterisation for the role of metastatic-related genes was investigated through in vitro migration and invasion assays. For clinical relevance, TMAs were used for immunohistochemistry assay. Results: The mutation spectrum was similar to that of previous studies. TP53, APC and KRAS were the three most frequently mutated genes, with no significant difference of mutation frequency between primary tumors from patients with liver metastasis and those from other patients. Notably, four recurrently mutated genes (FBXW7, EDIL3, KCNK9 and PCDHGA7) were identified exclusively in the tumors associated with liver metastasis. Furthermore, in vitro analyses showed that EDIL3 and KCNK9 overexpression resulted in enhanced cell migration and invasion, while CRISPR-mediated deletion of FBXW7 and PCDHGA7 exhibited enhanced migratory and invasive properties as well. For clinical relevance, highly expressed EDIL3 and KCNK9 was significantly associated with liver metastasis, whereas the expression of FBXW7 and PCDHGA7 negatively correlated with it in our cohorts. Pathway enrichment analysis also indicated a role for cell adhesion signaling in liver metastasis of CRC patients. Conclusion: Our study identified candidate genes, which might response to the initiation of metastasis, exclusively mutated in tumors associated with liver metastasis. These findings also provided potential therapeutic targets for personalized treatment. Note: This abstract was not presented at the meeting. Citation Format: Yanlei Ma, Wenhao Weng, Yongzhi Yang, Qing Wei, Sanjun Cai. Whole exome sequencing analyses of colorectal cancers associated with liver metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2711. doi:10.1158/1538-7445.AM2017-2711

Whole-Exome Sequencing Characterized the Landscape of Somatic Mutations and Pathways in Colorectal Cancer Liver Metastasis

Whole Exome Sequencing Analyses Of Colorectal Cancers Associated With Liver Metastasis

Abstract 2711: Whole Exome Sequencing Analyses of Colorectal Cancers Associated with Liver Metastasis

Whole Exome Sequencing Of Ulcerative Colitis-Associated Colorectal Cancer Based On Novel Somatic Mutations Identified In Chinese Patients

Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing

Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors

Whole exome and transcriptome sequencing reveal clonal evolution and exhibit immune-related features in metastatic colorectal tumors

Differential Genetic Variations and Prognostic Predicting Factors in Colorectal Cancer Patients with or Without Liver Metastasis.

TP53 Mutation is Enriched in Colorectal Cancer Liver Metastasis in the Context of Polyclonal Seeding.

Next-Generation Sequencing Characterizes the Landscape of Somatic Mutations and Pathways in Metastatic Bile Tract Carcinoma

Genomic Profiling of Colorectal Cancer with Isolated Lung Metastasis

The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique

Whole-genome Sequencing of Matched Primary and Metastatic Hepatocellular Carcinomas

Whole Exome Sequencing of Ulcerative Colitis–associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients

Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer

Next Generation Sequencing Reveals the Phylogenetic Relationship of Multi-Organ Metastatic Colon Cancer and Molecular Determinants of Metastasis.

Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing

Prognostic Impact Of Mutation Profiling In Chinese Patients With Colorectal Liver Metastases.

Whole-exome sequencing identifies somatic mutations associated with lung cancer metastasis to the brain

Mutational Landscape and Evolutionary Pattern of Peritoneal Metastases in Colorectal Cancer.